Explore our latest company news, blogs, scientific publications, or upcoming events
MANCHESTER, N.H., September 30, 2024 — BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced
GTC will provide BioAI with access to characterized imaging data to train AI algorithms for product development and sponsored projects.
Translational oncology expert joins BioAI as latest addition to growing scientific advisory board MANCHESTER, N.H., Aug. 29, 2023 — BioAI Health, a leader in AI-powered
Accomplished Chief Medical Officer joins executive team for emerging Biotech company to propel digital pathology outcomes forward
Veteran life sciences executive joins advisory board for emerging Biotech company to drive commercial strategy MANCHESTER, N.H., March 22, 2023 /PRNewswire/ — BioAI Health, an
Veteran digital biomarker executive joins emerging company in precision medicine to further enterprise go-to market success. MANCHESTER, N.H., Feb. 28, 2023 /PRNewswire/ — BioAI Health,
